Psilocybin
Clinical Use of Ayahuasca in Brazil
This study explores the articulations between the ritual use of ayahuasca by Indigenous and religious communities, the scientific interest in its therapeutic…
Ritual use of hallucinogens and psychedelic medicine: Articulations around the clinical use of ayahuasca in Brazil
Author: Genís Oña Journal: Quaderns de l’Institut Català d’Antropologia Year: 2023About the study
This study explores the articulations between the ritual use of ayahuasca by Indigenous and religious communities, the scientific interest in its therapeutic effects and the hegemonic psychotherapeutic models built around hallucinogens.Abstract
There is currently a renewed academic interest in hallucinogenic drugs such as psilocybin or ayahuasca. The clinical use of hallucinogens has been accompanied by psychotherapeutic models that address their subjective effects. The clinical approach developed in Brazil is particularly interesting, since it does not have psychotherapeutic orientations or techniques of directionality of the subjective experience. This text discusses the complex crossroads that crystallize in Brazil and that occur between the use of ayahuasca in clinical settings, its use by Indigenous communities and religions, the relationships between these communities and the general Brazilian population, and the hegemonic therapeutic models built around hallucinogens. Link to the study Contact ICEERS Research team Photo by Guto de Lima on Flickr. The post Clinical Use of Ayahuasca in Brazil appeared first on ICEERS. ayahuasca psilocybin psychedelic hallucinogenic regulation research-
Psychedelics1 week ago
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support
-
Law & Regulation1 week ago
FDA to weigh safety, impact of MDMA therapy for PTSD at June meeting
-
Psychedelics1 week ago
MindMed Reports First Quarter 2024 Financial Results and Business Updates
-
Psychedelics1 week ago
Optimi Health Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University’s Institute for Psychedelic Research
-
Law & Regulation1 week ago
Compass Pathways keeps plugging away with its psilocybin study trials
-
Psilocybin1 week ago
Oregon authorities give Kaya Holdings license for psilocybin treatment clinic
-
Ketamine1 week ago
Clinical-Stage BioTech Drug Stocks Portfolio UP 7% In w/e May 3rd
-
Psychedelics1 week ago
Optimi Health Provides Corporate Update